POSTER SESSION IV
Tuesday, March 20, 2012   —  1:00 PM - 4:30 PM
CC Exhibit Hall B3 & C


Click on the blue numbers in parentheses to display abstracts.
Click the button next to any title to add to Itinerary Planner...


GENITOURINARY PATHOLOGY



Poster#Title and AuthorsItinerary
Planner
79 CD44 Full-Thickness Immunoreactivity Is More Sensitive Than CK5/6 for the Diagnosis of Flat Urothelial Lesions with Atypia (1071)
W Yu, SA Umar, S Yasir, M Jorda - University of Miami Miller School of Medicine, Jackson Memorial Hospital, Sylvester Comprehensive Cancer Center, Miami, FL 		Add
80 MAGE-A Expression Is Associated with Features of Biologically Aggressive Urothelial Carcinoma of the Bladder (911)
F Khani, EK Cha, B Volkmer, M Rink, YT Chen, DS Scherr, MA Rubin, JM Mosquera, RE Hautmann, K Kuefer, SF Shariat, BD Robinson - Weill Cornell Medical College, New York; Klinikum Kassel, Kassel, Germany; Hospital Ulm, Ulm, Germany 		Add
81 The Immunohistochemical Profile of the Plasmacytoid Variant of Urothelial Carcinoma: A Study of 11 Cases (903)
C-S Kao, M Idrees, L Cheng, DJ Grignon - Indiana University, Indianapolis, IN 		Add
82 The Role of Immunohistochemistry (IHC) in the Differential Diagnosis of Invasive Plasmacytoid Urothelial Carcinoma (PUC) and Its Mimics (833)
KL Dishongh, JK McKenney, AR Sangoi, N Gokden - University of Arkansas for Medical Sciences, Little Rock, AR; Stanford University School of Medicine, Stanford, CA; El Camino Hospital, Mountain View, CA 		Add
83 GATA3, p63 and S100P: An IHC Comparison Analysis in Bladder Cancer (1023)
D Tacha, R Bremer, C Yu, L Chen - Biocare Medical, Concord, CA; Indiana University School of Medicine, Indianapolis, IN 		Add
84 Utility of Gata3 in the Diagnosis of Urothelial Carcinoma (815)
A Chang, A Amin, P Illei, E Gabrielson, JI Epstein - The Johns Hopkins Hospital, Baltimore 		Add
85 GATA3 Is Down-Regulated in Bladder Cancer yet Strong Expression Is an Independent Predictor of Poor Prognosis in Invasive Tumor (954)
H Miyamoto, K Izumi, JL Yao, Q Yang, LA McMahon, N Gonzalez-Roibon, A Chaux, DG Hicks, GJ Netto, D Tacha - University of Rochester, Rochester, NY; Johns Hopkins Medical Institution, Baltimore, MD; Biocare Medical, Concord, CA 		Add
86 Potential Utility of GATA3 Immunoexpression and HPV Status in the Differential Diagnosis of Urothelial vs Squamous Cell Carcinomas of Distal Penile Urethra (881)
JS Han, GJ Netto, S Lee, N Gonzalez-Roibon, H Ross, R Sharma, AL Cubilla, A Chaux - Johns Hopkins University, Baltimore, MD; Instituto de Patologia e Investigacion, Asuncion, Paraguay 		Add
87 Utility of Gata3 and Pax8 Immunohistochemistry in Diagnosing Sarcomatoid Urothelial Carcinoma (UC) and Sarcomatoid Renal Cell Carcinoma (RCC) (816)
A Chang, F Brimo, EA Montgomery, JI Epstein - The Johns Hopkins Hospital, Baltimore 		Add
88 Variability of Smoothelin Expression in Muscularis Propria of the Urinary Bladder: A Diagnostic Pitfall (1010)
UN Sheikh, MI Zulfiqar, A Shahab, PJ Kowalski, H Qu - Saint John Hospital & Medical Center, Detroit, MI 		Add
89 Nephrogenic Adenoma Showing a Flat Pattern. Description of a New Histological Variant of a Rare Benign Lesion Using PAX-2 and PAX-8 Immunohistochemistry (983)
S Pina-Oviedo, JY Ro - The Methodist Hospital, Houston, TX 		Add
90 Expression of Novel Renal Tubular Associated Markers in Nephrogenic Adenoma (NA) of the Urothelial Tract: Potential Utility in Distinction from Its Malignant Mimics (957)
SK Mohanty, N Nese, M Amin, M Aron, R Parakh, R Gupta, P Zhang, D Luthringer, MB Amin - Cedars-Sinai Medical Center, Los Angeles, CA; Beaumont Medical Center, Royal Oak, MI 		Add
91 Decreased p63 Expression Is Common in Micropapillary Urothelial Carcinoma (MPUC) and High Grade Urothelial Carcinoma (HGUC) (1081)
B Zhu, X Lin, S Rohan, M Zhong, R Goyal, E Gersbach, X Yang - Northwestern University, Chicago 		Add
92 Expression of Syndecan-1 (CD138) in Bladder Cancer with Emphasis on Conventional Urothelial Carcinoma and Urothelial Carcinoma with Squamous Differentiation (978)
S Patel, AO Osunkoya, C Ormenisan, GM Oprea-Ilies - Emory University, Atlanta, GA 		Add
93 Signet Ring Cell Adenocarcinoma of Urinary Bladder: Clinicopathologic Features of Patients Undergoing Radical Cystectomy (945)
SN Masineni, SA Boorjian, I Frank, P Thapa, JC Cheville - Mayo Clinic, Rochester, MN; Mayo Clnic, Rochester, MN 		Add
94 Micropapillary Urothelial Carcinoma: A Clinicopathological Study of the Experience of One Academic Center (1082)
B Zhu, X Lin, S Rohan, M Zhong, R Goyal, E Gersbach, X Yang - Northwestern University, Chicago 		Add
95 Clinicopathologic and Immunohistochemical Characteristics of Invasive Low Grade Urothelial Carcinoma (1051)
KE Watts, DE Hansel - Cleveland Clinic, Cleveland, OH 		Add
96 Expression of a-Methylacyl-CoA Racemase (AMACR) in Urothelial Carcinoma In Situ (CIS): Comparative Utility with More Traditional Markers (CK20,CD44s,p53) in the Distinction of Urothelial CIS and Reactive Urothelial Atypia (789)
M Aron, DJ Luthringer, JK McKenney, DE Hansel, DE Westfall, R Parkh, M Vankalakunti, SK Mohanty, BL Balzer, MB Amin - Cedars-Sinai Medical Center, Los Angeles; Stanford School of Medicine, Stanford; Cleveland Clinic, Cleveland 		Add
97 High Risk Human Papilloma Virus DNA Detected in Primary Squamous Cell Carcinoma of Urinary Bladder (817)
J Chapman-Fredericks, M Cioffi-Lavina, M Accola, W Rehrauer, M Garcia-Buitrago, C Gomez-Fernandez, P Ganjei- Azar, R Cote, M Jorda - University of Miami, Jackson Memorail Hospital, Sylvester Cancer Center, Miami, FL; University of Wisconsin School of Medicine, Madison, WI 		Add
98 Urothelial Carcinoma with Prominent Squamous Differentiation in the Setting of Neurogenic Bladder – Role of HPV Infection (805)
EB Blochin, KJ Park, SK Tickoo, VE Reuter, H Al-Ahmadie - Memorial Sloan-Kettering Cancer Center, New York, NY; Ackerman Academy of Dermatopathology, New York, NY 		Add
99 A Subset of Invasive Urothelial Carcinomas of the Renal Pelvis Show Immunoreactivity with the Monoclonal Anti- PAX8 Antibody (892)
J Hughes, AR Sangoi, JK McKenney - Stanford University, Stanford, CA; El Camino Hospital, Mountain View, CA 		Add
100 Imunohistochemical Profiles of Urothelial Carcinomas from Upper Urogenital Tract Versus Lower Tract. Does PAX8 Have Any Role? (1005)
J Schwartz, R Malhotra, P Zhang, M Amin - William Beaumont Hospital, Royal Oak, MI 		Add
101 Overexpression of the Soluble Epoxide Hydrolase in Human Prostate Adenocarcinoma with a Downregulation Following Androgen Deprivation Therapy (832)
X Ding, J Liao, H Li, J Huang, G-Y Yang - Northwestern University Feinberg School of Medicine, Chicago, IL; David Geffen School of Medicine at UCLA, Los Angeles, CA 		Add
102 Genome Expression Profiling of Holoclones Derived from Prostate Cancer (1001)
Y Salley, M Gallagher, S Elbaruni, P Smyth, C Spillane, CM Martin, W Watson, OM Sheils, JJ O´Leary - Trinity College Dublin, Dublin, Ireland; Conway Institute, University College Dublin, Dublin, Ireland 		Add
103 Acquired Mitochondrial DNA Mutations in Metastatic Prostatic Adenocarcinoma (981)
JA Petros, RS Arnold, LD True, LW Chung, AO Osunkoya - Emory University School of Medicine, Atlanta; Cedars-Sinai Medical Center, Los Angeles; University of Washington, Seattle 		Add
104 Neoadjuvant Docetaxel Treatment for Locally Advanced Prostate Cancer Affects miRNA Expression: A Pilot Study (842)
SM Falzarano, M Zhou, P Carver, EA Klein, R Dreicer, C Magi-Galluzzi - Cleveland Clinic, Cleveland, OH 		Add
105 Molecular Prognostic Markers of Prostate Cancer: An Immunohistochemical Study on TMA Blocks from 428 Radical Prostatectomy Specimens (901)
WY Jung, JY Ro, YM Cho - University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea; Cornell University, The Methodist Hospital, Houston, TX 		Add
106 Molecular Factors Showing Multivariate Significance for Outcome in a Conservatively Treated Prostate Cancer Biopsy Cohort (796)
D Berney, G Fisher, ZH Yang, H Moller, S Kudahetti, C Foster, V Reuter, P Scardino, J Cuzick - Barts and the London School of Medicine, London, United Kingdom; Memorial Sloan-Kettering Cancer Center, New York; Kings College London, London, United Kingdom; University of Liverpool, Liverpool, United Kingdom 		Add
107 Molecular Characterization of Gleason Pattern 3 Prostate Cancer with Co-Existing Adjacent Gleason Pattern 4 Cancer (1015)
AG Sowalsky, H Ye, SP Balk - Beth Israel Deaconess Medical Center, Boston, MA 		Add
108 Matrix Metalloproteinase-14: A Novel Marker of Tumor Progression and Invasion in Prostate Cancer (897)
G Javid, R Aljumaily, R Kaimal, S Sharifi, A Agarwal - Tufts Medical Center, Boston, MA 		Add
109 Seminal Plasma Proteins in Prostate Cancer: Increased Semenogelin I Expression Is a Predictor of Biochemical Recurrence after Radical Prostatectomy (896)
K Izumi, Y Li, Y Zheng, Q Yang, LA McMahon, J Gordetsky, JL Yao, H Miyamoto - University of Rochester, Rochester, NY 		Add
110 C-Terminal Portion of Group 3 POTEs Antigen Correlates with Progression of Prostate Cancer (1076)
X Zhou, Z He, S Redfield, K Brown, S Bigler - University of Mississippi Medical Center, Jackson 		Add
111 Rearrangement of the ETS Genes ETV-1, ETV-4, ETV-5 and LK-1 Is a Clonal Event during Prostate Cancer Progression (809)
M Braun, Z Shaikibrahim, P Nikolov, D Boehm, W Vogel, R Menon, V Scheble, F Fend, G Kristiansen, N Wernert, S Perner - University Hospital of Bonn, Bonn, Germany; University Hospital of Tuebingen, Tuebingen, Germany 		Add
112 Mitosis Phase Enrichment with Identification of Mitotic Centromere-Associated Kinesin as a Therapeutic Target in Castration-Resistant Prostate Cancer (1012)
K Sircar, H Huang, L Hu, Y Liu, J Dhillon, D Cogdell, A Aprikian, N Navone, P Troncoso, W Zhang - MD Anderson Cancer Center, Houston, TX; UT Arlington, TX; McGill University, Montreal, QC, Canada 		Add
113 Concurrent AURKA and MYCN Amplification in Primary Prostate Adenocarcinoma Is Associated with the Development of Lethal Neuroendocrine Prostate Cancer (974)
K Park, H Beltran, TY MacDonald, ST Tagawa, DM Nanus, MA Rubin, JM Mosquera - Weill Medical College of Cornell University, New York, NY 		Add
114 Microvessel Density Is Not Increased in Prostate Cancer: Digital Imaging of Tissue Microarray and Routine Sections (787)
T Antic, D Binder, M Kocherginsky, C Liao, J Taxy, A Oto, M Tretiakova - University of Chicago, Chicago 		Add
115 Role of Frozen Section Analysis during Radical Prostatectomy: A 1,993-Case Experience (902)
Y Kakiuchi, J Gordetsky, H Miyamoto - University of Rochester, Rochester, NY 		Add
116 Incidental Prostate Pathology in Cytoprostatectomy Specimens: Is Partial Prostate Sampling Adequate? (848)
E Filter, MY Gabril, JA Gomez, P Wang, J Izawa, J Chin, M Moussa - London Health Sciences Centre, London, ON, Canada 		Add
117 Correlation between Laterality of Pelvic Lymph Node Metastases and Tumor Laterality in Biopsy and Prostatectomy Specimens from Patients Undergoing Extended Pelvic Lymph Node Dissection (ePLND) (1032)
P Troncoso, S Matin, KN Babaian, IN Prokhorova, JW Davis - The University of Texas MD Anderson Cancer Center, Houston, TX 		Add